The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector FunctionRobert J. Johnston, Jane L. Grogan, Laëtitia Comps‐Agrar et al.|Cancer Cell|2014Cited by 1.1k
CD8+ T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapyMahrukh Huseni, Nathaniel R. West|Cell Reports Medicine|2023Cited by 181
CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non–Small Cell Lung Cancer After a Checkpoint Inhibitor and ChemotherapyJoel W. Neal, Thomas Newsom-Davis, Daniel C. Christoph et al.|Journal of Clinical Oncology|2024Cited by 57
Adjuvant Atezolizumab in Patients with Sarcomatoid Renal Cell Carcinoma: A Prespecified Subgroup Analysis of IMmotion010José A. Karam, Viraj A. Master, Robert G. Uzzo et al.|European Urology Oncology|2024Cited by 4